e-learning
resources
Stockholm 2007
Monday 17.09.2007
Towards an understanding of asthma pathogenesis - novel
in vitro
assays and results from animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Allergen-induced bronchial asthma in the factor V Leiden mouse
T. Takagi, E. C. Gabazza, H. Nakahara, H. Fujimoto, A. Yamaguchi, T. Kobayashi, H. Kobayashi, C. N. D‘Alessandro-Gabazza, O. Taguchi (Tsu, Mie, Japan)
Source:
Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel
in vitro
assays and results from animal models
Session:
Towards an understanding of asthma pathogenesis - novel
in vitro
assays and results from animal models
Session type:
Thematic Poster Session
Number:
2203
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Takagi, E. C. Gabazza, H. Nakahara, H. Fujimoto, A. Yamaguchi, T. Kobayashi, H. Kobayashi, C. N. D‘Alessandro-Gabazza, O. Taguchi (Tsu, Mie, Japan). Allergen-induced bronchial asthma in the factor V Leiden mouse. Eur Respir J 2007; 30: Suppl. 51, 2203
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Transcription factor GATA-3 as a specific marker of allergic bronchial asthma
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Gene polymorphism of epidermal growth factor receptor (EGFR) and airway hyperresponsiveness (AHR) in young allergic subjects without respiratory symptoms
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Is atopy an important factor of bronchial hyperresponsiveness in asthmatic patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 368s
Year: 2001
Hepatocyte growth factor attenuates airway hyperresponsiveness and airway inflammation in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 27s
Year: 2002
Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats
Source: Eur Respir J 2007; 30: 31-39
Year: 2007
Deficiency of tenascin C attenuates airway hyperresponsiveness in an experimental model of bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 585s
Year: 2005
LSC 2014 abstract - RORgamma t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002
-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
GATA-3 or T-bet: Who is the crucial marker of allergic bronchial asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats
Source: Eur Respir J 2006; 27: 726-734
Year: 2006
Increased bronchial hyperreactivity (BHR) in sarcoidosis patients maybe a risk factor for progression of the disease
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness
Source: Eur Respir J 2009; 33: 1287-1294
Year: 2009
TRPM8 polymorphism as an independent factor of bronchial obstruction in asthma
Source: International Congress 2018 – Role of omics in population studies
Year: 2018
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001
LATE-BREAKING ABSTRACT: The coagulant factor Xa induces PAR-1 and annexin A2-dependent airway smooth muscle cytokine production and cell proliferation.
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Nerve growth factor (NGF) gene polymorphism in allergic asthma
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
Analysis of risk factors of bronchial hyperresponsiveness in Estonia
Source: Eur Respir J 2006; 28: Suppl. 50, 239s
Year: 2006
Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking
Source: Eur Respir J 2002; 20: 86-91
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept